IBD Diagnostic/Monitoring Test
Inflammatory Bowel Disease (Crohn's, Colitis)
DevelopmentActive
Key Facts
Indication
Inflammatory Bowel Disease (Crohn's, Colitis)
Phase
Development
Status
Active
Company
About Metabiomics
Founded in 2010, Metabiomics is a private diagnostics company pioneering the use of the gut microbiome for disease detection and health assessment. Its core technology platform analyzes stool samples to identify specific microbial DNA markers associated with gastrointestinal pathologies, aiming to offer alternatives to invasive procedures like colonoscopies. The company appears to be in a late-development or early-commercial stage with its lead test for colorectal cancer screening. Its success hinges on clinical validation, market adoption against established screening methods, and navigating the complex reimbursement landscape for novel diagnostics.
View full company profile